Details of the Drug

General Information of Drug (ID: DMYAXNM)

Drug Name
SRK-015
Synonyms Apitegromab
Indication
Disease Entry ICD 11 Status REF
Spinal muscular atrophy 8B61 Phase 2 [1]
Drug Type
Antibody
Cross-matching ID
UNII
UZ54216N0Y
DrugBank ID
DB16096
TTD ID
DN5J9R

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Myostatin (MSTN) TTM8I2X GDF8_HUMAN Inhibitor [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT03921528) An Active Treatment Study of SRK-015 in Patients With Type 2 or Type 3 Spinal Muscular Atrophy (TOPAZ). U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of Scholar Rock.